Researchers selecting among these compounds typically consider the primary molecular target, model system compatibility, and whether single-mechanism or multi-mechanism study designs best address the research hypothesis
GLP-1 medications significantly slow how quickly food moves from your stomach to your small intestine
A Cesarean childbirth involves cutting of abdominal skin and muscles to deliver your baby
In fact, a double-masked, placebo-controlled study found that Byetta (exenatide, AstraZeneca), a GLP-1 receptor agonist for diabetes, lowered intracranial pressure (ICP) by 5.7 cm H 2 O within 2.5 hours in women with active IIH ( P = .048), a benefit that was sustained across 12 weeks
The gradual dose escalation, usually at 4-week intervals, helps minimize gastrointestinal adverse effects that commonly occur with GLP-1 receptor agonist therapy